Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Nozza

Showing results (61-70 of 230) with videos related to

Pageof 23
Sort By:
HIV Clinical Trials|July 13, 2004
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretroviralsDonato Torre, Filippo Speranza, Silvia Ghezzi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 22, 2020
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrierChiara Oltolini, Simona Piemontese, Marco Ripa, et al.
Viruses|May 25, 2024
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic ResponseAngelo Roberto Raccagni, Alessandro Mancon, Sara Diotallevi, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infectionSilvia Nozza, Andrea Poli, Marco Ripa, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' responseSilvia Nozza, Andrea Poli, Marco Ripa, et al.
The New Microbiologica|October 21, 2015
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
The New Microbiologica|March 1, 2016
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
Diseases (Basel, Switzerland)|March 27, 2026
Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in ItalyLuca Degli Esposti, Stefania Mazzoni, Maria Cappuccilli, et al.
The Journal of Infectious Diseases|January 6, 2026
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccinationNicolò Moschetta, Elena Criscuolo, Angelo Roberto Raccagni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2023
Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed VaccinationAngelo Roberto Raccagni, Daniele Ceccarelli, Benedetta Trentacapilli, et al.
Pageof 23

Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
HIV Clinical Trials|July 13, 2004
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretroviralsDonato Torre, Filippo Speranza, Silvia Ghezzi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 22, 2020
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrierChiara Oltolini, Simona Piemontese, Marco Ripa, et al.
Viruses|May 25, 2024
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic ResponseAngelo Roberto Raccagni, Alessandro Mancon, Sara Diotallevi, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infectionSilvia Nozza, Andrea Poli, Marco Ripa, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' responseSilvia Nozza, Andrea Poli, Marco Ripa, et al.
The New Microbiologica|October 21, 2015
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
The New Microbiologica|March 1, 2016
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
Diseases (Basel, Switzerland)|March 27, 2026
Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in ItalyLuca Degli Esposti, Stefania Mazzoni, Maria Cappuccilli, et al.
The Journal of Infectious Diseases|January 6, 2026
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccinationNicolò Moschetta, Elena Criscuolo, Angelo Roberto Raccagni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 23, 2023
Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed VaccinationAngelo Roberto Raccagni, Daniele Ceccarelli, Benedetta Trentacapilli, et al.
Pageof 23